Abstract
The amygdalae are a pair of small brain structures, each of which is composed of three main subregions and whose function is implicated in neuropsychiatric conditions. Functional Magnetic Resonance Imaging (fMRI) has been utilised extensively in investigation of amygdala activation and functional connectivity with most clinical research sites now utilising 3 Tesla (3T) MR systems. However, accurate imaging and analysis remains challenging not just due to the small size of the amygdala, but also its location deep in the temporal lobe. Selection of imaging parameters can significantly impact data quality with implications for the accuracy of study results and validity of conclusions. Wide variation exists in acquisition protocols with spatial resolution of some protocols suboptimal for accurate assessment of the amygdala as a whole, and for measuring activation and functional connectivity of the three main subregions, each of which contains multiple nuclei with specialised roles. The primary objective of this scoping review is to provide a comprehensive overview of 3T fMRI protocols in use to image the activation and functional connectivity of the amygdala with particular reference to spatial resolution. The secondary objective is to provide context for a discussion culminating in recommendations for a standardised protocol for imaging activation of the amygdala and its subregions. As the advantages of big data and protocol harmonisation in imaging become more apparent so, too, do the disadvantages of data heterogeneity.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Protocols
https://www.medrxiv.org/content/10.1101/2022.04.14.22273332v1.full-text
Funding Statement
This work was supported by first author funding from the Westmead Charitable Trust, Westmead Hospital.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
↵5 Co-Senior Authors.
Data Availability
All data produced in the present study are available upon reasonable request to the authors
